Based on comprehensive Fever Package testing data (2023–2025), close to one-third of patients were diagnosed with dengue, typhoid and other serious infections Mumbai, 27th March 2026: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has released new
POST TAGS:
Chikungunya IndiaCo-infections IndiaDengue IndiaDiagnostic InsightsDisease Trends IndiaFever AwarenessFever DiagnosisFever Study IndiaHealthcare Diagnostics IndiaInfectious Diseases IndiaLaboratory Testing IndiaLeptospirosis IndiaLiver EnzymesMalaria IndiaPlatelet CountPreventive Healthcare IndiaPublic Health IndiaSeasonal Diseases IndiaThyrocare TechnologiesTyphoid India
